Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender differences in Parkinson's disease

K E Lyons1, J P Hubble, A I Tröster

  • 1Department of Neurology, University of Kansas Medical Center, Kansas City 66160-7314, USA.

Clinical Neuropharmacology
|May 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

Nature aging·2026
Same author

Evaluation of morning bradykinesia in Parkinson's disease in a United States cohort using continuous objective monitoring.

Clinical parkinsonism & related disorders·2022
Same author

Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease.

Cerebral cortex communications·2021
Same author

Successes and optimism in deep brain stimulation for neurological disorders: ripe for a surgical time out?

European journal of neurology·2018
Same author

The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.

International journal of obesity (2005)·2016
Same author

Semantic fluency performance of patients with cortical and subcortical neurodegenerative diseases.

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition·2014
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

Gender differences in Parkinson's disease (PD) emerge with disease progression. Men show more motor symptoms, while women experience increased dyskinesia, particularly after five years of PD.

Area of Science:

  • Neurology
  • Neuroscience
  • Movement Disorders

Background:

  • Parkinson's disease (PD) affects millions globally.
  • Understanding gender-specific symptom presentation is crucial for tailored treatment strategies.
  • Previous research on gender differences in PD has yielded mixed results.

Purpose of the Study:

  • To investigate potential gender disparities in cognitive and motor symptoms of Parkinson's disease.
  • To analyze how these differences evolve with disease duration.

Main Methods:

  • Retrospective analysis of data from 630 patients in the University of Kansas Medical Center's Parkinson's Disease Registry.
  • Assessment of cognitive function using the Mini-Mental State Examination.
  • Evaluation of motor and non-motor symptoms via the Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn and Yahr Staging, and Schwab and England Scale.

Related Experiment Videos

Main Results:

  • Women scored slightly higher on the Mini-Mental State Examination.
  • Women demonstrated significantly better motor scores on the UPDRS but had a higher prevalence of dyskinesia.
  • These motor differences and dyskinesia prevalence were significant only in patients with PD duration exceeding five years.

Conclusions:

  • Gender differences in Parkinson's disease become apparent as the condition progresses.
  • Men tend to exhibit more severe parkinsonian motor features over time.
  • Women are more likely to experience levodopa-induced dyskinesia as PD advances.